{"url_path":"/sec/sxtc/10-k/2026/item-8","section_key":"item-8","section_title":"Item 8 FINANCIAL INFORMATION","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1723980/0001213900-26-074310-index.html","accession_number":"0001213900-26-074310","cik":"0001723980","ticker":"SXTC","issuer_name":"China SXT Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1723980/0001213900-26-074310-index.html","primary_entity_key":"0001723980","primary_entity_name":"China SXT Pharmaceuticals, Inc."},"word_count":125,"has_tables":true,"body_markdown":"ITEM 8. FINANCIAL INFORMATION\n\n \n\n8.A. Consolidated Statements and Other Financial\nInformation\n\n \n\nThe financial statements\nrequired by this item may be found at the end of this report on 20-F, beginning on page F-1.\n\n \n\nLegal Proceedings\n\n \n\nSee “Item 4. Information\non the Company-B. Business Overview-Legal Proceedings.”\n\n \n\nDividends\n\n \n\nWe have never declared or\npaid any dividend on our Class A Ordinary Shares and we do not anticipate paying any dividends on our Class A Ordinary Shares in the\nfuture. We currently intend to retain all future earnings to finance our operations and to expand our business.\n\n \n\n8.B. Significant Changes\n\n \n\nExcept as disclosed elsewhere\nin this annual report, no other significant changes to our financial condition have occurred since the date of the annual financial statements\ncontained herein."}